This poster is published under an
open license. Please read the
disclaimer for further details.
Keywords:
Lymphoma, Dosimetric comparison, Biological effects, Radiation safety, Radiation effects, Dosimetry, MR-Diffusion/Perfusion, CT, Radioprotection / Radiation dose, Oncology, Lymph nodes
Authors:
S. Kharuzhyk, E. Leusik; Minsk/BY
DOI:
10.1594/ecr2014/C-0306
References
1.
Kwee TC,
Kwee RM,
Nievelstein RA.
Imaging in staging of malignant lymphoma: a systematic review.
Blood 2008; 111:504-16.
2.
Brenner DJ,
Hall EJ.
Computed tomography – an increasing source of radiation exposure.
N Engl J Med 2007; 357:2277-84.
3.
The 2007 Recommendations of the International Commission on Radiological Protection.
ICRP publication 103.
Ann ICRP 2007; 37:1-332.
4.
Berrington de Gonzalez A,
Darby S.
Risk of cancer from diagnostic x-rays: estimates for the UK and 14 other countries.
Lancet 2004; 363:345-51.
5.
Kharuzhyk SA,
Matskevich SA,
Filjustin AE,
et al.
Survey of computed tomography doses and establishment of national diagnostic reference levels in the Republic of Belarus.
Rad Prot Dosim 2010; 139:367-70.
6.
Sodickson A,
Baeyens PF,
Andriole KP,
et al.
Recurrent CT,
cumulative radiation exposure,
and associated radiation-induced cancer risks from CT of adults.
Radiology 2009; 251:175-84.
7.
Smith-Bindman R,
Lipson J,
Marcus R,
et al.
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.
Arch Intern Med 2009; 169:2078-86.
8.
Einstein AJ,
Henzlova MJ,
Rajagopalan S.
Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography.
JAMA 2007; 298:317-23.